DOI:
10.1055/s-00035331
Revista Urología Colombiana / Colombian Urology Journal
LinksClose Window
References
Kato D, Tabuchi H, Uno S.
Three-year safety, efficacy and persistence data following the daily use of mirabegron for overactive bladder in the clinical setting: A Japanese post-marketing surveillance study.
Low Urin Tract Symptoms 2019;
11 (02) O152-O161
DOI: 10.1111/luts.12237.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.